Vlad Coric - 05 Apr 2024 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role: Chief Executive Officer, Director
Signature: /s/ George Clark, Attorney-in-Fact
Issuer symbol: BHVN
Transactions as of: 05 Apr 2024
Net transactions value: $0
Form type: 4
Filing time: 05 Apr 2024, 20:21:14 UTC
Previous filing: 08 Mar 2024
Next filing: 23 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Ownership	Footnotes
transaction	BHVN	Common Shares	Award	+232	+0.01%	1,666,466	05 Apr 2024	Direct	F1
transaction	BHVN	Common Shares	Award	+231	+0.03%	840,890	05 Apr 2024	By: The Vlad Coric Family Trust	F1, F2
transaction	BHVN	Common Shares	Award	+231	+0.06%	407,213	05 Apr 2024	By: The Vladimir Coric Marital Trust	F1, F2
holding	BHVN	Common Shares				109,565	05 Apr 2024	By: 401(K) Plan

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3. The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.
F2	These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3. The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.

These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.